The need to implement non-industry COVID-19 clinical trials in non-high-income countries

J Glob Health. 2020 Jun;10(1):010351. doi: 10.7189/jogh.10.010351.

Authors

Rafael Dal-Ré¹, Antonio J Carcas², Nadarajah Sreeharan³

Affiliations

¹ Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain.
² Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
³ Department of Medicine, University of Jaffna, Jaffna, Sri Lanka.

No abstract available

Publication types

Review

MeSH terms

COVID-19
Coronavirus Infections / drug therapy*
Coronavirus Infections / epidemiology
Developing Countries*
Drug Industry
Humans
Pandemics
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / epidemiology
Randomized Controlled Trials as Topic*